Jim Weiss (Indapta Therapeutics)
Overview
Jim Weiss is a prominent figure in the biotechnology and healthcare sectors, known primarily for his leadership role at Real Chemistry, a global health innovation company he founded. Weiss has been instrumental in bridging data-driven insights with health solutions, having evolved Real Chemistry from a one-person consultancy into a significant player in healthcare communications. Additionally, Weiss is recognized for his contributions as a board member and advisor within the biotechnology industry, including his position at Indapta Therapeutics, a company focused on developing natural killer cell therapies for treating cancer.
Recent Developments
- April 2025: Indapta Therapeutics, with Jim Weiss as a board member, continues to make significant strides in its G-NK cell therapy development. The company is actively engaged in advancing clinical trials for these therapies.
- November 2023: Jim Weiss was awarded the Trailblazer Lifetime Achievement Award by PM360, recognizing his influence and contributions to healthcare communications and innovation.
- May 2023: Indapta Therapeutics received FDA clearance for its investigational new drug application for IDP-023, paving the way for phase I clinical trials, a move supported and advocated by Weiss.
- 2022: Weiss took on the role of Chairman at Real Chemistry, allowing him to focus more on advisory roles in biopharma and medical tech sectors, including his work with Indapta Therapeutics.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Jim Weiss |
| Born | Not publicly available |
| Nationality | American |
| Occupation | Founder & Chairman of Real Chemistry |
| Known For | Founder of Real Chemistry; Board Member at Indapta Therapeutics |
| Net Worth | Not publicly available |
| Education | Graduated from the S.I. Newhouse School of Public Communications at Syracuse University |
Early Life and Education
Jim Weiss graduated from the S.I. Newhouse School of Public Communications at Syracuse University, which was pivotal in his early career development. His education in communications served as a foundation for his innovative approaches in the health communications sector. Throughout his formative years, Weiss was drawn to the cross-section of data, communications, and health, which culminated in his future endeavors in founding Real Chemistry.
Career and Notable Achievements
Jim Weiss's career trajectory has been marked by significant achievements:
- Founder of Real Chemistry (2001): Weiss started what is now known as Real Chemistry as a solo consultancy focusing on healthcare communications, eventually expanding it into a global leader in health innovation.
- Advancements in Data-Driven Health Solutions: Weiss has been a pioneer in integrating real-world data and analytics into health care strategies, significantly impacting the sector’s approach to communications and patient engagement.
- Board Member and Influencer: Beyond Real Chemistry, Weiss holds influential positions on the boards of several biotech firms, including Indapta Therapeutics, which focuses on cancer therapies using natural killer cell technology.
- Awards and Recognitions: Over the years, Weiss has been recognized with several accolades, including being named a Top 50 Health Influencer multiple times and recently receiving the Trailblazer Lifetime Achievement Award from PM360 in 2023.
Current Work and Impact
Currently, Jim Weiss serves as the Chairman of Real Chemistry, focusing on expanding its global reach and impact through strategic partnerships. At Indapta Therapeutics, Weiss brings his expertise in strategic communications to aid in their cutting-edge advancements in natural killer cell therapies. His ongoing influence is seen in the company's progression towards real-world applications of their therapies in oncology and autoimmune diseases.